UNSPSC 51102847: Fluocinolone/neomycin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102847 Fluocinolone/neomycin is a Commodity code that captures pharmaceutical products and related medical supplies procured by state and local health agencies. The recent opportunities tagged to this code show a mismatch: the Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets (neither fluocinolone nor neomycin products), and Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems through a competitive IFB. The code shows limited relevant recent activity aligned with its nominal scope; the opportunities actually being procured under this code tag do not reflect topical combination products but rather broad-spectrum antibiotics and opioid-reversal agents, suggesting either classification drift or that the code receives minimal state and local volume in its actual intended scope.

State health departments and county public health agencies are the primary issuing bodies. Illinois Department of Public Health executed a competitive IFB award with a 12-month initial term and two optional renewal years, while Seminole County, Florida posted an IFB for quarterly deliveries with an initial two-year term and one-year renewal option. Geographic activity is concentrated in Florida and Illinois based on the recent record. The code does not support clear evidence of sustained, high-volume procurement activity in its nominal product category among state and local buyers.